Clinical Trials
9 trialsNCT07024615 2026-05-28
A Study of ASP2138 Given Before Surgery, Then Chemotherapy After Surgery, in People With Pancreatic Ductal Cancer
Astellas Pharma Inc
Phase 1 Recruiting
NCT04975217 2026-05-22
Fecal Microbial Transplants for the Treatment of Pancreatic Cancer
M.D. Anderson Cancer Center
Phase EARLY_PHASE1 Suspended
NCT05365893 2026-05-22
PHL Treatment in Pancreatic Cancer
Fox Chase Cancer Center
Phase EARLY_PHASE1 Active not recruiting
NCT03851237 2026-05-08
CCR2 PET for Pancreatic Cancer Imaging and Prediction of Response to Standard and CCR2-Targeted Therapy
Washington University School of Medicine
Phase 1 Completed
NCT05296421 2026-05-04
Investigating Targetable Metabolic Pathways Sustaining Pancreatic Cancer
Rutgers, The State University of New Jersey
Phase NA Recruiting
NCT05257993 2026-04-13
Study to Assess the Safety, Tolerability of JPI-547 in Combination With Modified FOLFIRINOX or Gemcitabine-nab-paclitaxel in Patients With Locally Advanced and Metastatic Pancreatic Cancer
Onconic Therapeutics Inc.
Phase 1/2 Recruiting
NCT05846516 2026-04-01
A Study to Test KISIMA-02 Vaccine-based Immunotherapy and Ezabenlimab in People With Pancreatic Cancer
Boehringer Ingelheim
Phase 1 Active not recruiting
NCT07324096 2026-03-27
AI-PACED
Mayo Clinic
Phase NA Recruiting
NCT07199764 2026-03-06
IGNITE
University of Pennsylvania
Phase 2 Recruiting